Industry News
HPV Infection Highly Prevalent Among Organ Transplant Recipients
Jul 12, 2011
A new study published in the American Journal of Transplantation reveals an association between the human papillomavirus (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in organ transplant recipients. HPV is known to cause cervical cancer and SCC in the anogenital area and also plays a role in some forms of head and neck cancer... Read More
Project Achilles Pinpoints Vulnerabilities In Ovarian Cancer
Jul 12, 2011
Cancer is not invincible but its weaknesses can be difficult to detect. An effort known as Project Achilles named after the Greek warrior whose one vulnerability led to his undoing was launched to develop a systematic way of pinpointing these weak spots... Read More
News From The Journal Of Clinical Investigation: July 11, 2011
Jul 12, 2011
METABOLIC DISEASE: Sex hormone protection from type 2 diabetes The incidence of obesity and its common complication, type 2 diabetes, is approaching epidemic proportions in the developed world. A key event in the development of type 2 diabetes is the failure of beta-cells in the pancreas to produce enough of the hormone insulin to meet the body's demands... Read More
A Possible Stepping Stone From Environmental Chemical To Cancer
Jul 12, 2011
Several chemicals that can accumulate to high levels in our body (for example BPA and some pesticides) have been recently linked to an increased risk of cancer and/or impaired responsiveness to anticancer drugs... Read More
Multi-Institutional Genetic Landmark Study Of Ovarian Cancer
Jul 11, 2011
A University of Houston researcher is an author on a landmark multi-institutional genetic study of the most aggressive and common form of ovarian cancer that is published in the current issue of the scientific journal Nature. Ovarian cancer is the fifth-leading cause of cancer death in women in the United States... Read More
Synta Announces Presentation Of Ganetespib Phase 2 Non-small Cell Lung Cancer Trial Results At IASLC 14th World Conference On Lung Cancer
Jul 08, 2011
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today presented results at the International Association for the Study of Lung Cancer (IASLC) 14th World Conference on Lung Cancer from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease... Read More
Researchers Examine How Genes And Proteins Affect Therapeutic Treatments For Lung Cancer
Jul 08, 2011
The Translational Genomics Research Institute (TGen) presented two key studies at the 14th World Conference on Lung Cancer, July 3-7 in Amsterdam. One study involved a gene called GLI1, which may limit the effectiveness of the most common combination chemotherapy given to patients with small cell lung cancer (SCLC)... Read More
Amrubicin Improved Response Rate And Progression-Free Survival Vs. Topotecan For Lung Cancer Patients In Phase III Trial
Jul 08, 2011
Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)... Read More
In Non-Small Cell Lung Cancer Patients, TEMLA Shows Higher Diagnostic Yield Than EBUS Or EUS In Largest Reported Series To Date
Jul 08, 2011
In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer (NSCLC), TEMLA showed a significantly higher diagnostic yield, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Assoc... Read More
For Lung Cancer Patients Endosonography Followed By Surgical Staging Improves Quality Of Life, According To ASTER Study
Jul 08, 2011
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)... Read More
Previous Page Next Page